Brief: Guardant Health Q3 Adjusted EPS USD -0.39 Vs. IBES Estimate USD -0.76
29/10/2025 20:05
Oct 29 (Reuters) - Guardant Health Q3 revenue USD 265.2 million vs. IBES estimate USD 235.7 million. Q3 adjusted net income USD -48.3 million vs. IBES estimate USD -98.5 million Q3 EPS USD -0.74 Q3 adjusted EBITDA USD -45.5 million vs. IBES estimate USD -54.7 million outlook FY revenue USD 965-970 million
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte